Company / Income Tax
Trevi Therapeutics, Inc. Income Tax History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
-$30.0K
FY2024
5-year range
-$36.0K / -$18.0K
FY2020-FY2024
Trend
+6.3%
vs FY2023
Sector context
#169 of 204
Health Care
What the data says
Trevi Therapeutics, Inc.'s income tax of -$30,000 is lower than 83% of companies in the Health Care sector (FY2024). Increased from -$36,000 to -$30,000 over the past 2 years.
Based on SEC 10-K filings.
-$30,000 in FY2024.
Increased from -$36,000 to -$30,000 over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 17% in Health CareTop 17% of 204This company -$30.0K Sector average $118.7M
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2024, income tax increased 6.3% year-over-year.
- Ranks #169 out of 204 companies in the Health Care sector.
- Peak income tax was recorded in FY2020.
- Lowest income tax in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.91 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$30.0K | +6.3% |
| FY2023 | -$32.0K | +11.1% |
| FY2022 | -$36.0K | -71.4% |
| FY2021 | -$21.0K | -16.7% |
| FY2020 | -$18.0K | +0.0% |
| FY2019 | -$18.0K | +85.5% |
| FY2018 | -$124.0K | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026